Sunpeaks Ventures Inc. (OTC: SNPK), a distributor of hard-to-find and specialty drugs to the healthcare provider market, has seen a rebound in its shares today.
SNPK shares, which have fallen sharply in the last few days, are up 33.33% to $0.208 in trading currently.
Sunpeaks Ventures shares are rebounding after the company announced the signing of a marketing and sponsorship agreement with a major university sports program.
SNPK signed a marketing and sponsorship agreement with a Division I-A college sports program under which the university will feature SNPK’s Clotamin® on field level signage during regular season home football games. Under the terms of the agreement, the university will also feature Clotamin in a full-page 4-color advertisement in the University football program. Clotamin will also receive online exposure.
Mackie A. Barch, CEO of Sunpeaks Ventures, said that the agreement is meant to leverage the success with local and national popularity of select well-known professional and college sports program.
Recent Comments